Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China.
Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China.
复制标题
甘油三酯介导的血清血管生成素样蛋白8对2型糖尿病患者亚临床动脉粥样硬化的影响:中国GDMD研究的结果
DOI:
10.1186/s12933-018-0687-y
复制
发表时间:
2018-07-15
影响因子:
9.3
通讯作者:
Song J
中科院分区:
文献类型:
--
作者:
Zheng T;Ge B;Liu H;Chen B;Qin L;Xiao L;Song J
Hypertriglyceridemia, insulin resistance and hyperglycemia are risk factors for atherosclerosis in type 2 diabetes. Angiopoietin-like protein 8 (ANGPTL8) is a newly identified liver-derived hormone related to these risk factors. Hence, we aimed to explore the correlations between serum levels of ANGPTL8 and subclinical atherosclerosis in type 2 diabetes. We measured serum ANGPTL8, blood lipids, blood glucose, common carotid artery Intima-Media Thickness (c-IMT) and calculated homeostasis model assessment of insulin resistance in (1) control subjects (n = 100), (2) type 2 diabetic patients without subclinical atherosclerosis (n = 100), and (3) type 2 diabetic patients with subclinical atherosclerosis (n = 100). Serum levels of ANGPTL8 and triglyceride (TG) were significantly increased in type 2 diabetic patients with subclinical atherosclerosis as compared with type 2 diabetic patients without subclinical atherosclerosis and control subjects (P < 0.001). ANGPTL8 was positively associated with age, TG, diabetes duration, and c-IMT in type 2 diabetes. Logistic regression analysis revealed that ANGPTL8 had higher odds of having subclinical atherosclerosis [odds ratio (OR) 2.90, 95% confidence interval (CI) 1.48–5.70, P = 0.002] in type 2 diabetes. Mediation analysis indicated that TG acted as a partial mediator in the relationship between ANGPTL8 and c-IMT. TG partially mediates the positive relationship between ANGPTL8 and c-IMT. Our data provide the first evidence for a strong link between ANGPTL8 and subclinical atherosclerosis, suggesting ANGPTL8 to be a new biomarker for subclinical atherosclerosis in type 2 diabetes.
登录
查看更多内容
影响因子:
9.3
作者:
Chen CC;Susanto H;Chuang WH;Liu TY;Wang CH
通讯作者:
Wang CH
影响因子:
7.6
作者:
BARON, RM;KENNY, DA
通讯作者:
KENNY, DA
影响因子:
--
作者:
Yue S;Wu J;Zhang J;Liu L;Chen L
通讯作者:
Chen L
影响因子:
3.7
作者:
Gao T;Jin K;Chen P;Jin H;Yang L;Xie X;Yang M;Hu C;Yu X
通讯作者:
Yu X
影响因子:
6.9
作者:
Guo, Kaifeng;Lu, Junxi;Jia, Weiping
通讯作者:
Jia, Weiping